Real-time enrollment status for this multiple sclerosis clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:19 PM UTC
| NCT Number | NCT04047628 |
| Recruiting Status | Recruiting |
| Condition | Multiple Sclerosis |
| Phase | PHASE3 |
| Target Enrollment | 156 participants |
| Active Locations | 22 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | January 6, 2026 (Jan 6, 2026) |
As of July 18, 2026: Clinical trial NCT04047628 is currently recruiting participants. This phase3 study for multiple sclerosis is actively seeking new participants at 22 locations across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04047628 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04047628 was last updated Jan 6, 2026 (January 6, 2026). HelloStudys verifies this status automatically.